Literature DB >> 17403447

Relationship between human herpesvirus 8 loads and disease stage in classic Kaposi sarcoma patients.

Emma Guttman-Yassky1, Rinat Abada, Zipi Kra-Oz, Judith Sattinger, Alex Perelman, Reuven Bergman, Ronit Sarid.   

Abstract

Human herpesvirus 8 (HHV-8), also known as Kaposi sarcoma (KS)-associated herpesvirus, is causally implicated in all forms of KS, including the classic form. Our objective was to investigate the relationship between HHV-8 load in peripheral blood mononuclear cells (PBMCs) and the stage of the disease in classic KS (CKS) patients. HHV-8 loads were measured in 41 PBMC samples from CKS patients with different Krigel-based classification stages using a quantitative real-time polymerase chain reaction assay. Low HHV-8 DNA loads reaching a maximum of 75.5 copies/10(5) cells were detected in 73.2% of the patients. HHV-8 loads in patients with stages I and II were similarly distributed. An increased detection rate of HHV-8 DNA, although not statistically significant, was evident in patients diagnosed with CKS stages III and IV. We conclude that the measurements of HHV-8 load in PBMCs provide a limited correlation with the clinical stage of KS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17403447     DOI: 10.1016/j.diagmicrobio.2006.09.012

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  9 in total

1.  FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency.

Authors:  Ruoyun Gao; Tingting Li; Brandon Tan; Suzane Ramos da Silva; Jae U Jung; Pinghui Feng; Shou-Jiang Gao
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

2.  Viral Bcl-2 Encoded by the Kaposi's Sarcoma-Associated Herpesvirus Is Vital for Virus Reactivation.

Authors:  Anastasia Gelgor; Inna Kalt; Shir Bergson; Kevin F Brulois; Jae U Jung; Ronit Sarid
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

3.  The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection.

Authors:  Jie Lu; Subhash C Verma; Qiliang Cai; Erle S Robertson
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

4.  Fluorescent tagging and cellular distribution of the Kaposi's sarcoma-associated herpesvirus ORF45 tegument protein.

Authors:  Shir Bergson; Inna Kalt; Inbal Itzhak; Kevin F Brulois; Jae U Jung; Ronit Sarid
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

5.  LANA-1, Bcl-2, Mcl-1 and HIF-1alpha protein expression in HIV-associated Kaposi sarcoma.

Authors:  E Long; M Ilie; V Hofman; K Havet; E Selva; C Butori; J P Lacour; A M Nelson; G Cathomas; P Hofman
Journal:  Virchows Arch       Date:  2009-05-30       Impact factor: 4.064

6.  Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers.

Authors:  Dirk P Dittmer; Kristy L Richards; Blossom Damania
Journal:  Front Microbiol       Date:  2012-04-18       Impact factor: 5.640

7.  Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation.

Authors:  Fengchun Ye; Xiufen Lei; Shou-Jiang Gao
Journal:  Adv Virol       Date:  2011

8.  Restricted Kaposi's sarcoma (KS) herpesvirus transcription in KS lesions from patients on successful antiretroviral therapy.

Authors:  Dirk P Dittmer
Journal:  MBio       Date:  2011-11-01       Impact factor: 7.867

9.  Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda.

Authors:  Christine Johnston; Jackson Orem; Fred Okuku; Mary Kalinaki; Misty Saracino; Edward Katongole-Mbidde; Merle Sande; Allan Ronald; Keith McAdam; Meei-Li Huang; Linda Drolette; Stacy Selke; Anna Wald; Lawrence Corey; Corey Casper
Journal:  PLoS One       Date:  2009-01-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.